The virtual gathering of the biotech industry will be one of the largest venues to be celebrated in 2020. It will allow companies to access key partners to explore opportunities and share the latest drug discovery and development insights. BIO International Convention 2020 will also help to drive successful deals in the biopharma industry.
Raul Insa, CEO of SOM Biotech: “We look forward to meeting with key executives and decision-makers. These meetings will enable us to evaluate new partnerships for our AI-based drug discovery technology and for the most advanced asset in our pipeline, SOM3355 for Chorea in Huntington’s disease. This year´s event is also marked by the impact of COVID-19 on the global pharmaceutical market dynamics. Now, more than ever, it is essential for biotech companies to forge collaborations and partnerships to advance innovation. That will boost and accelerate drug development and, as a result, facilitate the patients’ access to innovative and safe therapies.”